Kayne Anderson Rudnick Investment Management’s Abiomed Inc ABMD Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2	Closed	-$1K	–	743
2020 Q4	$1K	Buy	+2	New	+$553	﹤0.01%	681
2020 Q1	–	Sell	-39,505	Closed	-$6.74M	–	692
2019 Q4	$6.74M	Buy	39,505 +3,823	+11%	+$709K	0.03%	205
2019 Q3	$6.35M	Buy	35,682 +8,765	+33%	+$1.89M	0.03%	205
2019 Q2	$7.01M	Buy	26,917 +12,983	+93%	+$3.44M	0.04%	198
2019 Q1	$3.98M	Buy	13,934 +6,134	+79%	+$2.04M	0.02%	219
2018 Q4	$2.54M	Buy	+7,800	New	+$2.71M	0.02%	246

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's ABMD Position: Q1 2021 in Review

Kayne Anderson Rudnick Investment Management sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 2 shares — an estimated $1K sold.

Kayne Anderson Rudnick Investment Management first reported a position in ABMD in Q4 2018 and held it in 6 quarters. The position peaked at $7.01M in Q2 2019. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

Kayne Anderson Rudnick Investment Management reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
Kayne Anderson Rudnick Investment Management sold 2 Abiomed Inc shares in Q1 2021, an estimated $1K.
Kayne Anderson Rudnick Investment Management first reported a position in Abiomed Inc in Q4 2018 and held it in 6 quarters.
Kayne Anderson Rudnick Investment Management's Abiomed Inc position peaked at $7.01M in Q2 2019.
487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2021, filed 17 May 2021.